CHAG priming regimen containing of cytarabine, aclacinomycin homoharringtonine and G-CSF for relapsed refractory acute myelogenous leukemia: a modified combination chemotherapeutic combination

Leuk Lymphoma. 2013 Oct;54(10):2291-3. doi: 10.3109/10428194.2013.772295. Epub 2013 Mar 8.

Authors

Lin Chen¹, Qingsong Yin, Ruihua Mi, Xudong Wei

Affiliation

¹ Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University , Zhengzhou , China.

PMID: 23369043
DOI: 10.3109/10428194.2013.772295

No abstract available

Publication types

Letter

MeSH terms

Aclarubicin / administration & dosage
Aclarubicin / analogs & derivatives
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cytarabine / administration & dosage
Granulocyte Colony-Stimulating Factor / administration & dosage
Harringtonines / administration & dosage
Homoharringtonine
Humans
Leukemia, Myeloid, Acute / drug therapy*
Leukemia, Myeloid, Acute / mortality
Treatment Outcome

Substances

Harringtonines
aclacinomycins
Cytarabine
Granulocyte Colony-Stimulating Factor
Homoharringtonine
Aclarubicin